109 related articles for article (PubMed ID: 3058014)
1. Comparisons of verapamil administration twice and three times daily in hypertension.
Salmela PI; Gordin A; Salo H; Ottoila P; Jounela AJ
Ann Clin Res; 1988; 20(3):195-200. PubMed ID: 3058014
[TBL] [Abstract][Full Text] [Related]
2. Twice-daily administration of oral verapamil in the treatment of essential hypertension.
Frishman W; Charlap S; Kimmel B; Saltzberg S; Stroh J; Weinberg P; Monuszko E; Wiezner J; Dorsa F; Pollack S
Arch Intern Med; 1986 Mar; 146(3):561-5. PubMed ID: 3954530
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive efficacy of sustained-release verapamil.
Zachariah PK; Sheps SG; Oshrain C; Schirger A; Stein WJ
J Clin Hypertens; 1987 Dec; 3(4):536-46. PubMed ID: 3330987
[TBL] [Abstract][Full Text] [Related]
4. Propranolol-hydralazine combination in essential hypertension.
Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
[TBL] [Abstract][Full Text] [Related]
5. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
Weir MR; Cassidy CA; Hall PS; Lancaster A; Schubert C; Urick A; Saunders E; Kong BW; Jenkins P; Lavin PT
Clin Ther; 1990; 12(2):139-48. PubMed ID: 2354483
[TBL] [Abstract][Full Text] [Related]
7. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
Pathak L; Hiremath ; Kerkar PG; Manade VG
J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schriger A
J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
[TBL] [Abstract][Full Text] [Related]
9. A new sustained-release formulation of verapamil in the treatment of hypertension.
Midtbo KA; Hals O; Lauve O
J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.
Frishman WH; Eisen G; Charlap S; Strom JA
J Clin Hypertens; 1987 Dec; 3(4):605-9. PubMed ID: 3134517
[TBL] [Abstract][Full Text] [Related]
11. Twice-daily nicardipine in the treatment of essential hypertension.
Charlap S; Kimmel B; Laifer L; Weinberg P; Singer M; Lazar E; Saltzberg S; Dorsa F; Kafka K; Strom J
J Clin Hypertens; 1986 Sep; 2(3):271-7. PubMed ID: 3537214
[TBL] [Abstract][Full Text] [Related]
12. Amiloride compared with nitrendipine in treatment of essential hypertension.
Katzman PL; Henningsen NC; Hulthén UL
J Hum Hypertens; 1988 Oct; 2(3):147-51. PubMed ID: 3236318
[TBL] [Abstract][Full Text] [Related]
13. Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions.
Lenz ML; Pool JL; Laddu AR; Varghese A; Johnston W; Taylor AA
Am J Hypertens; 1995 Feb; 8(2):133-45. PubMed ID: 7755941
[TBL] [Abstract][Full Text] [Related]
14. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
15. Clonidine in mild to moderate hypertension: effects on blood pressure and serum lipoproteins.
Karlberg BE; Lins LE; Rössner S
J Hypertens Suppl; 1985 Dec; 3(4):S69-71. PubMed ID: 3913756
[TBL] [Abstract][Full Text] [Related]
16. Verapamil compared with nifedipine in the treatment of essential hypertension.
Midtbø K; Hals O; van der Meer J
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S363-8. PubMed ID: 6184569
[TBL] [Abstract][Full Text] [Related]
17. Propranolol-hydrochlorothiazide combination in essential hypertension.
Stevens JD; Mullane JF
Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
[TBL] [Abstract][Full Text] [Related]
19. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
Hartikainen M; Heikkilä J
Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
[TBL] [Abstract][Full Text] [Related]
20. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
